KAZIA Therapeutics Ltd (kza) Logo

KAZIA Therapeutics Ltd (KZA)

___:___ · Healthcare
ASX Delayed
Cboe unavailable

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

KZA ASX Chart

Snapshot

Kazia Therapeutics Limited (KZA) is an oncology-focused drug development company, based in Sydney, Australia. The company's lead program is paxalisib, a brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. The company is also developing EVT801, a small-molecule inhibitor of VEGFR3, which was licensed from Evotec SE in April 2021. Preclinical data has shown EVT801 to be active against a broad range of tumour types and has provided compelling evidence of synergy with immuno-oncology agents.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -32.35%
vs ASX 200 (1yr) -29.10%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,497 of 2,358
Sector Rank 138 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies -
EPS $0.00
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

KZA is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office
Website -
Registry Computershare
Auditor BDO Audit Pty Ltd
Date Listed 1 Sep 1994

Upcoming Calendar (Forecasted)

No calendar entries available.

Former Company Names

  • Novogen Limited (NRT), 28/11/2017
  • Norvet Limited (NRT), 30/04/1997

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

KZA directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
20/03/23 Steven Coffey Buy +135,000 $0.12 $16,200 Off-market trade
13/03/23 Bryce Carmine Buy +135,000 $0.12 $16,200 Off-market trade
03/03/23 Bryce Carmine Buy +181,819 $0.11 $20,000 Participation in share purchase plan
03/03/23 James Garner Buy +181,819 $0.11 $20,000 Participation in share purchase plan
03/03/23 Steven Coffey Buy +272,728 $0.11 $30,000 Participation in share purchase plan
03/03/23 Iain Ross Buy +272,728 $0.11 $30,000 Participation in share purchase plan
07/09/22 James Garner Buy +100,000 $0.231 $23,135 On-market trade
07/09/22 Steven Coffey Buy +50,000 $0.223 $11,158 On-market trade
06/09/22 Bryce Carmine Buy +120,000 $0.235 $28,200 On-market trade
06/09/22 Iain Ross Buy +175,000 $0.221 $38,622 On-market trade
20/12/21 Bryce Carmine Buy +47,169 $1.07 $50,470 On-market trade
20/12/21 Steven Coffey Buy +50,000 $1.08 $54,154 On-market trade
16/12/21 Iain Ross Buy +50,000 $1.06 $53,150 On-market trade
16/12/21 James Garner Buy +50,000 $1.08 $53,864 On-market trade
27/08/21 Iain Ross Buy +25,000 $1.37 $34,250 On-market trade
27/08/21 James Garner Buy +20,000 $1.38 $27,623 On-market trade
02/06/21 Steven Coffey Buy +8,000 $1.25 $9,968 On-market trade
31/05/21 Bryce Carmine Buy +20,000 $1.24 $24,700 On-market trade
31/05/21 James Garner Buy +10,000 $1.24 $12,430 On-market trade
03/05/21 James Garner Buy +20,000 $1.39 $27,880 On-market trade
03/05/21 Steven Coffey Buy +7,250 $1.40 $10,150 On-market trade
30/04/21 Iain Ross Buy +25,000 $1.40 $34,925 On-market trade
17/12/20 Steven Coffey Buy +8,500 $1.24 $10,540 On-market trade
17/12/20 Steven Coffey Buy +8,015 $1.22 $9,818 On-market trade
16/12/20 Iain Ross Buy +30,000 $1.24 $37,200 On-market trade
11/12/20 James Garner Buy +37,500 $1.41 $52,950 On-market trade
09/11/20 Bryce Carmine Issued 400,000 $0.895 $358,000 Employee Share Ownership Plan
09/11/20 Iain Ross Issued 400,000 $0.895 $358,000 Employee Share Ownership Plan
09/11/20 James Garner Issued 800,000 $0.895 $716,000 Employee Share Ownership Plan
09/11/20 Steven Coffey Issued 400,000 $0.895 $358,000 Employee Share Ownership Plan
12/10/20 Bryce Carmine Issued 62,500 $0.80 $50,000 Rights issue
12/10/20 Steven Coffey Issued 62,500 $0.80 $50,000 Rights issue
12/10/20 James Garner Issued 62,500 $0.80 $50,000 Rights issue
12/10/20 Iain Ross Issued 125,000 $0.80 $100,000 Rights issue
31/08/20 Steven Coffey Expiry 5,875 $1.09 $6,433 Options expired
31/08/20 Steven Coffey Buy +13,526 $1.07 $14,432 On-market trade
28/08/20 Bryce Carmine Buy +23,900 $12.69 $303,250 On-market trade
27/08/20 Iain Ross Buy +20,000 $1.01 $20,120 On-market trade
27/08/20 James Garner Buy +25,000 $1.02 $25,450 On-market trade
25/05/20 Iain Ross Buy +125,000 $0.411 $51,325 On-market trade
11/05/20 Bryce Carmine Issued 75,000 $0.40 $30,000 Participation in share purchase plan
11/05/20 Iain Ross Issued 75,000 $0.40 $30,000 Participation in share purchase plan
11/05/20 James Garner Issued 75,000 $0.40 $30,000 Participation in share purchase plan
11/05/20 Steven Coffey Issued 75,000 $0.40 $30,000 Participation in share purchase plan
20/02/20 Steven Coffey Buy +10,000 $0.61 $6,103 On-market trade
20/02/20 James Garner Buy +15,000 $0.635 $9,525 On-market trade
20/02/20 James Garner Buy +15,000 $0.635 $9,525 On-market trade
02/12/19 James Garner Buy +65,000 $0.331 $21,507 Off-market trade
26/11/19 Iain Ross Buy +125,000 $0.331 $41,359 Off-market trade
20/11/19 Bryce Carmine Buy +60,000 $0.331 $19,852 Off-market trade
19/11/19 Steven Coffey Buy +60,000 $0.331 $19,852 Off-market trade
13/11/19 James Garner Cancelled 750,000 $0.41 $307,500 Cancellation of securities
13/11/19 James Garner Issued 1,200,000 $0.41 $492,000 Employee Share Ownership Plan
03/09/19 James Garner Buy +5,000 $0.38 $1,900 On-market trade
30/08/19 James Garner Buy +1,500 $0.38 $570 On-market trade
29/08/19 James Garner Buy +3,500 $0.373 $1,305 On-market trade
03/07/19 James Garner Buy +65,000 $0.331 $21,507 Off-market trade
03/07/19 Iain Ross Buy +125,000 $0.331 $41,359 Off-market trade
04/04/19 James Garner Buy +10,000 $0.464 $4,638 On-market trade
02/04/19 Iain Ross Buy +65,527 $0.47 $30,770 On-market trade
06/12/18 James Garner Buy +5,526 $0.405 $2,238 On-market trade
04/12/18 James Garner Buy +5,000 $0.405 $2,025 On-market trade
08/11/18 Iain Ross Buy +50,000 $0.41 $20,500 On-market trade
17/11/17 Iain Ross Buy +39,474 $0.38 $15,000 Participation in share purchase plan
27/06/17 Bryce Carmine Buy +194,882 $0.049 $9,549 On-market trade
26/06/17 Bryce Carmine Buy +270,702 $0.049 $13,264 On-market trade
23/06/17 Bryce Carmine Buy +34,797 $0.049 $1,705 On-market trade
13/06/17 Iain Ross Buy +500,000 $0.057 $28,252 On-market trade
13/06/17 James Garner Buy +125,000 $0.057 $7,125 On-market trade
13/06/17 Steven Coffey Buy +320,000 $0.057 $18,240 On-market trade
24/02/17 Steven Coffey Buy +18,000 $0.085 $1,530 On-market trade
23/02/17 Steven Coffey Buy +82,000 $0.086 $7,052 On-market trade
23/02/17 James Garner Buy +125,000 $0.09 $11,250 On-market trade
03/11/16 James Garner Buy +100,000 $0.084 $8,400 On-market trade
01/11/16 Iain Ross Buy +250,000 $0.091 $22,750 On-market trade
04/05/16 Iain Ross Buy +250,000 $0.115 $28,750 On-market trade
21/03/16 Iain Ross Buy +200,000 $0.12 $24,000 On-market trade
18/03/16 James Garner Issued 7,500,000 $0.115 $862,500 Issue of options
07/03/16 Ian Phillips Buy +2,800 $2.08 $5,824 On-market trade
23/02/16 Bryce Carmine Buy +318,181 $0.11 $35,000 On-market trade
22/02/16 James Garner Buy +70,000 $0.108 $7,560 On-market trade
11/12/15 Iain Ross Buy +100,000 $0.125 $12,500 On-market trade
21/09/15 Iain Ross Buy +100,000 $0.167 $16,740 On-market trade
18/09/15 Iain Ross Buy +100,000 $0.164 $16,350 On-market trade
04/06/15 John O'Connor Issued 69,652 $0.245 $17,065 Rights issue
04/06/15 Steven Coffey Issued 117,494 $0.30 $35,248 Rights issue
04/06/15 Steven Coffey Issued 176,241 $0.245 $43,179 Rights issue
04/06/15 Graham Kelly Issued 100,090 $0.30 $30,027 Rights issue
04/06/15 Graham Kelly Issued 15,000 $0.30 $4,500 Rights issue
04/06/15 Graham Kelly Issued 176,241 $0.245 $43,179 Rights issue
04/06/15 John O'Connor Issued 43,012 $0.30 $12,904 Rights issue
04/06/15 John O'Connor Issued 3,422 $0.30 $1,027 Rights issue
29/04/15 Steven Coffey Exercise 128,727 $0.125 $16,091 Exercise of options
29/04/15 Steven Coffey Buy +128,727 $0.125 $16,091 Exercise of options
15/01/15 Graham Kelly Transfer 513,654 $0.098 $50,338 Off-market transfer
18/11/14 Graham Kelly Buy +181,818 $0.09 $16,364 As advised by the company
18/11/14 Steven Coffey Buy +272,727 $0.09 $24,545 As advised by the company
18/11/14 Graham Kelly Buy +181,818 $0.11 $20,000 As advised by the company
18/11/14 Steven Coffey Buy +272,727 $0.11 $30,000 As advised by the company
Show All

Director Interests

The current holdings of KZA directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Bryce Carmine 31/08/2023 856,681 N/A 400,000 N/A
Steven Coffey 31/08/2023 8,015 983,978 400,000 N/A
John Friend 01/08/2023 N/A N/A 4,800,000 N/A
Ebru Davidson 05/06/2023 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 28, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 106,665,493 45.13%
Willoughby Capital Pty Ltd <Willoughby Capital A/C> 24,815,910 10.50%
Bnp Paribas Noms Pty Ltd <Drp> 9,081,774 3.84%
Mr Francis Samson 6,090,000 2.58%
Hishenk Pty Ltd 6,000,000 2.54%
Mna Family Holdings Pty Ltd <Hishenk Pty Ltd Super A/C> 3,725,000 1.58%
Mr Peter Alan Luedeke and Mrs Julia Luedeke <Luedeke Retirement Fund A/C> 3,404,359 1.44%
Citicorp Nominees Pty Limited 2,323,597 0.98%
Jamplat Pty Ltd 1,569,728 0.66%
Mr Iain Ross 1,522,729 0.64%
Brispot Nominees Pty Ltd <House Head Nominee A/C> 1,397,108 0.59%
Netwealth Investments Limited <Wrap Services A/C> 1,351,400 0.57%
Dr Andrew Heaton 1,234,087 0.52%
D & G Brown Investments Pty Limited 1,048,232 0.44%
Da Silva Company Pty Ltd <Dasilva Super Fund A/C> 1,000,001 0.42%
Mr Venkat Subbu Ghantala and Mrs Lavanya Ghantala 1,000,000 0.42%
Mr Bryce Deller Carmine 856,681 0.36%
Mr David Lim 804,241 0.34%
Mrs Bianca Arneaud 751,523 0.32%
Dr James Stuart Garner 750,000 0.32%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Willoughby Capital Pty Ltd 28/08/2023 30,112,339 15.95
Platinum Investment Management Limited 28/08/2023 23,083,022 9.77
The Bank of New York Mellon Corporation 10/11/2023 114,288,976 48.36

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
10-11-23 The Bank of New York Mellon Corporation 25,909,840 37.39 48.36
06-11-23 The Bank of New York Mellon Corporation 2,368,840 36.39 37.79
19-10-23 The Bank of New York Mellon Corporation 2,796,560 35.21 36.39

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.07 31 October
2023 $0.16 30 June
2022 $0.615 30 June
2021 $1.31 30 June
2020 $0.48 30 June
2019 $0.35 28 June
2018 $0.425 29 June
2017 $0.05 30 June
2016 $0.097 30 June
2015 $0.215 30 June
2014 $0.145 30 June
KZA Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.